US Stock MarketDetailed Quotes

AUPH Aurinia Pharmaceuticals

Watchlist

4.910
+0.040+0.82%

Close Apr 26 16:00 ET

4.900
-0.010-0.20%

Post 19:43 ET

710.07MMarket Cap-9092P/E (TTM)

Aurinia Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

57.93%-33.46M

36.96%14.31M

13.57%-13.28M

89.86%-2.83M

32.25%-31.67M

49.57%-79.53M

140.31%10.45M

61.83%-15.36M

26.61%-27.87M

12.69%-46.75M

Net income from continuing operations

27.88%-78.02M

-3.18%-26.88M

-49.59%-13.45M

67.64%-11.49M

30.36%-26.21M

40.22%-108.18M

21.84%-26.05M

82.11%-8.99M

24.45%-35.52M

25.31%-37.63M

Operating gains losses

--5.95M

----

Depreciation and amortization

330.41%11.65M

2,159.82%4.95M

550.43%5.26M

-14.40%719K

-14.44%717K

-1.99%2.71M

-70.04%219K

5.61%809K

-0.94%840K

101.44%838K

Other non cash items

6.02%-1.52M

208.22%2.4M

56.70%-675K

-230.19%-841K

-258.12%-2.39M

-116.12%-1.61M

-119.76%-2.21M

-111.21%-1.56M

181.46%646K

171.72%1.51M

Change In working capital

17.74%-5.61M

-39.21%19.43M

13.33%-13.9M

149.88%2.12M

28.32%-13.25M

68.49%-6.82M

1,869.88%31.96M

-36.39%-16.04M

-447.34%-4.25M

-99.08%-18.49M

-Change in receivables

-650.39%-10.61M

-51.01%13.86M

21.83%-18.45M

-120.51%-457K

-11.49%-5.56M

112.50%1.93M

605.05%28.28M

-337.24%-23.6M

168.96%2.23M

-320.05%-4.99M

-Change in inventory

-74.92%-15.87M

-1,021.34%-6.89M

-15.05%-581K

-39.19%-1.41M

-0.76%-6.99M

-60.74%-9.07M

-120.86%-614K

73.66%-505K

29.65%-1.01M

-245.45%-6.94M

-Change in prepaid assets

282.99%4.4M

589.50%7.29M

-462.22%-5.26M

76.75%-1.21M

1,068.73%3.59M

54.94%-2.4M

-12.35%1.06M

131.91%1.45M

-127.49%-5.22M

-0.32%307K

-Change in payables and accrued expense

1,816.17%13.39M

998.86%1.58M

48.48%10.57M

1,060.61%5.36M

38.59%-4.12M

-82.85%699K

-106.01%-176K

5,931.36%7.12M

-94.32%462K

5.62%-6.7M

-Change in other current assets

95.59%-16K

--0

100.19%1K

---17K

-202.83%-363K

340.57%467K

-1,838.89%-313K

---517K

--0

-Change in other current liabilities

-3.22%-673K

-72.28%-174K

8.16%-180K

12.83%-163K

7.14%-156K

-296.39%-652K

39.52%-101K

-553.33%-196K

-440.00%-187K

-135.44%-168K

-Change in other working capital

23.46%3.76M

----

--3.05M

----

Cash from discontinued investing activities

Operating cash flow

57.93%-33.46M

36.96%14.31M

13.57%-13.28M

89.86%-2.83M

32.25%-31.67M

49.57%-79.53M

140.31%10.45M

61.83%-15.36M

26.61%-27.87M

12.69%-46.75M

Investing cash flow

Cash flow from continuing investing activities

88.94%-6.71M

-107.32%-6.26M

60.77%-19.7M

-112.29%-5.61M

146.89%24.86M

41.63%-60.63M

45.00%-3.02M

-53.08%-50.22M

2,631.80%45.62M

21.16%-53.02M

Capital expenditure reported

----

---28K

---50K

---162K

----

--0

Net PPE purchase and sale

-145.89%-718K

-123.13%-299K

362.50%105K

-353.85%-177K

-339.24%-347K

3.63%-292K

---134K

---40K

---39K

41.91%-79K

Net intangibles purchase and sale

--0

----

--0

----

Net investment purchase and sale

109.85%5.88M

-138.20%-6.2M

60.28%-19.78M

-85.80%6.48M

147.92%25.37M

29.40%-59.68M

52.27%-2.6M

-86.21%-49.8M

2,313.32%45.66M

2.38%-52.94M

Net other investing changes

-1,689.44%-11.86M

--0

----

96.28%-663K

-205.22%-282K

----

Cash from discontinued investing activities

Investing cash flow

88.94%-6.71M

-107.32%-6.26M

60.77%-19.7M

-112.29%-5.61M

146.89%24.86M

41.63%-60.63M

45.00%-3.02M

-53.08%-50.22M

2,631.80%45.62M

21.16%-53.02M

Financing cash flow

Cash flow from continuing financing activities

-310.85%-5.13M

-910.61%-5.58M

-2.33M

-14.93%1.14M

304.69%1.64M

-98.90%2.43M

-99.67%688K

4.77%1.34M

-91.95%405K

Net issuance payments of debt

---10.03M

---6.54M

----

--0

----

Net common stock issuance

--0

----

--0

----

Proceeds from stock option exercised by employees

101.19%4.9M

40.41%966K

--1.15M

-14.93%1.14M

304.69%1.64M

-90.02%2.43M

-92.34%688K

--0

4.77%1.34M

-91.95%405K

Cash from discontinued financing activities

Financing cash flow

-310.85%-5.13M

-910.61%-5.58M

---2.33M

-14.93%1.14M

304.69%1.64M

-98.90%2.43M

-99.67%688K

--0

4.77%1.34M

-91.95%405K

Net cash flow

Beginning cash position

-59.39%94.17M

-46.08%46.4M

-46.11%81.71M

-32.85%89M

-59.39%94.17M

-14.85%231.9M

49.43%86.05M

24.74%151.63M

-15.36%132.54M

-14.85%231.9M

Current changes in cash

67.11%-45.3M

-69.48%2.48M

46.16%-35.31M

-138.21%-7.29M

94.80%-5.17M

-240.49%-137.73M

-95.34%8.12M

-2.51%-65.58M

154.50%19.09M

14.17%-99.36M

End cash Position

-48.10%48.88M

-46.08%46.4M

-46.11%81.71M

-32.85%89M

-59.39%94.17M

49.43%86.05M

24.74%151.63M

-15.36%132.54M

Free cash flow

57.18%-34.18M

38.16%14.25M

14.30%-13.2M

89.06%-3.05M

31.28%-32.18M

49.86%-79.82M

139.34%10.32M

61.88%-15.4M

26.24%-27.91M

14.43%-46.83M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	57.93%-33.46M	36.96%14.31M	13.57%-13.28M	89.86%-2.83M	32.25%-31.67M	49.57%-79.53M	140.31%10.45M	61.83%-15.36M	26.61%-27.87M	12.69%-46.75M
Net income from continuing operations	27.88%-78.02M	-3.18%-26.88M	-49.59%-13.45M	67.64%-11.49M	30.36%-26.21M	40.22%-108.18M	21.84%-26.05M	82.11%-8.99M	24.45%-35.52M	25.31%-37.63M
Operating gains losses	--5.95M	----	----	----	----	----	----	----	----	----
Depreciation and amortization	330.41%11.65M	2,159.82%4.95M	550.43%5.26M	-14.40%719K	-14.44%717K	-1.99%2.71M	-70.04%219K	5.61%809K	-0.94%840K	101.44%838K
Other non cash items	6.02%-1.52M	208.22%2.4M	56.70%-675K	-230.19%-841K	-258.12%-2.39M	-116.12%-1.61M	-119.76%-2.21M	-111.21%-1.56M	181.46%646K	171.72%1.51M
Change In working capital	17.74%-5.61M	-39.21%19.43M	13.33%-13.9M	149.88%2.12M	28.32%-13.25M	68.49%-6.82M	1,869.88%31.96M	-36.39%-16.04M	-447.34%-4.25M	-99.08%-18.49M
-Change in receivables	-650.39%-10.61M	-51.01%13.86M	21.83%-18.45M	-120.51%-457K	-11.49%-5.56M	112.50%1.93M	605.05%28.28M	-337.24%-23.6M	168.96%2.23M	-320.05%-4.99M
-Change in inventory	-74.92%-15.87M	-1,021.34%-6.89M	-15.05%-581K	-39.19%-1.41M	-0.76%-6.99M	-60.74%-9.07M	-120.86%-614K	73.66%-505K	29.65%-1.01M	-245.45%-6.94M
-Change in prepaid assets	282.99%4.4M	589.50%7.29M	-462.22%-5.26M	76.75%-1.21M	1,068.73%3.59M	54.94%-2.4M	-12.35%1.06M	131.91%1.45M	-127.49%-5.22M	-0.32%307K
-Change in payables and accrued expense	1,816.17%13.39M	998.86%1.58M	48.48%10.57M	1,060.61%5.36M	38.59%-4.12M	-82.85%699K	-106.01%-176K	5,931.36%7.12M	-94.32%462K	5.62%-6.7M
-Change in other current assets	95.59%-16K	--0	--0	100.19%1K	---17K	-202.83%-363K	340.57%467K	-1,838.89%-313K	---517K	--0
-Change in other current liabilities	-3.22%-673K	-72.28%-174K	8.16%-180K	12.83%-163K	7.14%-156K	-296.39%-652K	39.52%-101K	-553.33%-196K	-440.00%-187K	-135.44%-168K
-Change in other working capital	23.46%3.76M	----	----	----	----	--3.05M	----	----	----	----
Cash from discontinued investing activities
Operating cash flow	57.93%-33.46M	36.96%14.31M	13.57%-13.28M	89.86%-2.83M	32.25%-31.67M	49.57%-79.53M	140.31%10.45M	61.83%-15.36M	26.61%-27.87M	12.69%-46.75M
Investing cash flow
Cash flow from continuing investing activities	88.94%-6.71M	-107.32%-6.26M	60.77%-19.7M	-112.29%-5.61M	146.89%24.86M	41.63%-60.63M	45.00%-3.02M	-53.08%-50.22M	2,631.80%45.62M	21.16%-53.02M
Capital expenditure reported	----	----	---28K	---50K	---162K	----	----	--0	--0	--0
Net PPE purchase and sale	-145.89%-718K	-123.13%-299K	362.50%105K	-353.85%-177K	-339.24%-347K	3.63%-292K	---134K	---40K	---39K	41.91%-79K
Net intangibles purchase and sale	--0	----	----	----	----	--0	----	----	----	----
Net investment purchase and sale	109.85%5.88M	-138.20%-6.2M	60.28%-19.78M	-85.80%6.48M	147.92%25.37M	29.40%-59.68M	52.27%-2.6M	-86.21%-49.8M	2,313.32%45.66M	2.38%-52.94M
Net other investing changes	-1,689.44%-11.86M	--0	--0	----	----	96.28%-663K	-205.22%-282K	----	----	----
Cash from discontinued investing activities
Investing cash flow	88.94%-6.71M	-107.32%-6.26M	60.77%-19.7M	-112.29%-5.61M	146.89%24.86M	41.63%-60.63M	45.00%-3.02M	-53.08%-50.22M	2,631.80%45.62M	21.16%-53.02M
Financing cash flow
Cash flow from continuing financing activities	-310.85%-5.13M	-910.61%-5.58M	-2.33M	-14.93%1.14M	304.69%1.64M	-98.90%2.43M	-99.67%688K	0	4.77%1.34M	-91.95%405K
Net issuance payments of debt	---10.03M	---6.54M	----	----	----	--0	--0	----	----	----
Net common stock issuance	--0	----	----	----	----	--0	----	----	----	----
Proceeds from stock option exercised by employees	101.19%4.9M	40.41%966K	--1.15M	-14.93%1.14M	304.69%1.64M	-90.02%2.43M	-92.34%688K	--0	4.77%1.34M	-91.95%405K
Cash from discontinued financing activities
Financing cash flow	-310.85%-5.13M	-910.61%-5.58M	---2.33M	-14.93%1.14M	304.69%1.64M	-98.90%2.43M	-99.67%688K	--0	4.77%1.34M	-91.95%405K
Net cash flow
Beginning cash position	-59.39%94.17M	-46.08%46.4M	-46.11%81.71M	-32.85%89M	-59.39%94.17M	-14.85%231.9M	49.43%86.05M	24.74%151.63M	-15.36%132.54M	-14.85%231.9M
Current changes in cash	67.11%-45.3M	-69.48%2.48M	46.16%-35.31M	-138.21%-7.29M	94.80%-5.17M	-240.49%-137.73M	-95.34%8.12M	-2.51%-65.58M	154.50%19.09M	14.17%-99.36M
End cash Position	-48.10%48.88M	-48.10%48.88M	-46.08%46.4M	-46.11%81.71M	-32.85%89M	-59.39%94.17M	-59.39%94.17M	49.43%86.05M	24.74%151.63M	-15.36%132.54M
Free cash flow	57.18%-34.18M	38.16%14.25M	14.30%-13.2M	89.06%-3.05M	31.28%-32.18M	49.86%-79.82M	139.34%10.32M	61.88%-15.4M	26.24%-27.91M	14.43%-46.83M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall